Cervical cancer rates after the transition from annual pap to 3-year HPV and pap

Helen Dinkelspiel, Barbara Fetterman, Nancy Poitras, Walter Kinney, J. Thomas Cox, Thomas Lorey, Philip E. Castle

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

OBJECTIVE: Kaiser Permanente Northern California (KPNC) introduced 3-year Pap and human papillomavirus DNA cotesting for cervical cancer screening in women 30 years or older in 2003 to 2004. Patient and provider willingness to extend screening intervals and the impact on annual cervical cancer incidence after interval extension are evaluated. MATERIALS AND METHODS: Age-adjusted cervical cancer rates and screening intervals were calculated from KPNC Regional Laboratory databases and Northern California Cancer Registry from 2000 to 2009. RESULTS: The median screening interval between negative cotests was 36 months compared to the 16 months after a negative Pap test alone before the implementation of cotesting. The age-adjusted invasive cancer rate was 6.5 per 100,000 women in 2000 and 6.3 in 2009; there was no difference in the rates of cervical cancer in women 30 years or older from 2000 to 2009 (ptrend = .7). CONCLUSIONS: Patients and providers were compliant with the extension of screening intervals with cotesting. Cervical cancer rates remained constant during the 10-year study period despite extending screening intervals after a negative cotest.

Original languageEnglish (US)
Pages (from-to)57-60
Number of pages4
JournalJournal of Lower Genital Tract Disease
Volume18
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Uterine Cervical Neoplasms
Early Detection of Cancer
Papanicolaou Test
Registries
Neoplasms
Databases
DNA
Incidence

Keywords

  • cervical cancer screening
  • HPV testing
  • Pap

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Cervical cancer rates after the transition from annual pap to 3-year HPV and pap. / Dinkelspiel, Helen; Fetterman, Barbara; Poitras, Nancy; Kinney, Walter; Cox, J. Thomas; Lorey, Thomas; Castle, Philip E.

In: Journal of Lower Genital Tract Disease, Vol. 18, No. 1, 01.2014, p. 57-60.

Research output: Contribution to journalArticle

Dinkelspiel, Helen ; Fetterman, Barbara ; Poitras, Nancy ; Kinney, Walter ; Cox, J. Thomas ; Lorey, Thomas ; Castle, Philip E. / Cervical cancer rates after the transition from annual pap to 3-year HPV and pap. In: Journal of Lower Genital Tract Disease. 2014 ; Vol. 18, No. 1. pp. 57-60.
@article{41fe60c052824d8dbb764853a109a391,
title = "Cervical cancer rates after the transition from annual pap to 3-year HPV and pap",
abstract = "OBJECTIVE: Kaiser Permanente Northern California (KPNC) introduced 3-year Pap and human papillomavirus DNA cotesting for cervical cancer screening in women 30 years or older in 2003 to 2004. Patient and provider willingness to extend screening intervals and the impact on annual cervical cancer incidence after interval extension are evaluated. MATERIALS AND METHODS: Age-adjusted cervical cancer rates and screening intervals were calculated from KPNC Regional Laboratory databases and Northern California Cancer Registry from 2000 to 2009. RESULTS: The median screening interval between negative cotests was 36 months compared to the 16 months after a negative Pap test alone before the implementation of cotesting. The age-adjusted invasive cancer rate was 6.5 per 100,000 women in 2000 and 6.3 in 2009; there was no difference in the rates of cervical cancer in women 30 years or older from 2000 to 2009 (ptrend = .7). CONCLUSIONS: Patients and providers were compliant with the extension of screening intervals with cotesting. Cervical cancer rates remained constant during the 10-year study period despite extending screening intervals after a negative cotest.",
keywords = "cervical cancer screening, HPV testing, Pap",
author = "Helen Dinkelspiel and Barbara Fetterman and Nancy Poitras and Walter Kinney and Cox, {J. Thomas} and Thomas Lorey and Castle, {Philip E.}",
year = "2014",
month = "1",
doi = "10.1097/LGT.0b013e31829325c3",
language = "English (US)",
volume = "18",
pages = "57--60",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Cervical cancer rates after the transition from annual pap to 3-year HPV and pap

AU - Dinkelspiel, Helen

AU - Fetterman, Barbara

AU - Poitras, Nancy

AU - Kinney, Walter

AU - Cox, J. Thomas

AU - Lorey, Thomas

AU - Castle, Philip E.

PY - 2014/1

Y1 - 2014/1

N2 - OBJECTIVE: Kaiser Permanente Northern California (KPNC) introduced 3-year Pap and human papillomavirus DNA cotesting for cervical cancer screening in women 30 years or older in 2003 to 2004. Patient and provider willingness to extend screening intervals and the impact on annual cervical cancer incidence after interval extension are evaluated. MATERIALS AND METHODS: Age-adjusted cervical cancer rates and screening intervals were calculated from KPNC Regional Laboratory databases and Northern California Cancer Registry from 2000 to 2009. RESULTS: The median screening interval between negative cotests was 36 months compared to the 16 months after a negative Pap test alone before the implementation of cotesting. The age-adjusted invasive cancer rate was 6.5 per 100,000 women in 2000 and 6.3 in 2009; there was no difference in the rates of cervical cancer in women 30 years or older from 2000 to 2009 (ptrend = .7). CONCLUSIONS: Patients and providers were compliant with the extension of screening intervals with cotesting. Cervical cancer rates remained constant during the 10-year study period despite extending screening intervals after a negative cotest.

AB - OBJECTIVE: Kaiser Permanente Northern California (KPNC) introduced 3-year Pap and human papillomavirus DNA cotesting for cervical cancer screening in women 30 years or older in 2003 to 2004. Patient and provider willingness to extend screening intervals and the impact on annual cervical cancer incidence after interval extension are evaluated. MATERIALS AND METHODS: Age-adjusted cervical cancer rates and screening intervals were calculated from KPNC Regional Laboratory databases and Northern California Cancer Registry from 2000 to 2009. RESULTS: The median screening interval between negative cotests was 36 months compared to the 16 months after a negative Pap test alone before the implementation of cotesting. The age-adjusted invasive cancer rate was 6.5 per 100,000 women in 2000 and 6.3 in 2009; there was no difference in the rates of cervical cancer in women 30 years or older from 2000 to 2009 (ptrend = .7). CONCLUSIONS: Patients and providers were compliant with the extension of screening intervals with cotesting. Cervical cancer rates remained constant during the 10-year study period despite extending screening intervals after a negative cotest.

KW - cervical cancer screening

KW - HPV testing

KW - Pap

UR - http://www.scopus.com/inward/record.url?scp=84894101219&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84894101219&partnerID=8YFLogxK

U2 - 10.1097/LGT.0b013e31829325c3

DO - 10.1097/LGT.0b013e31829325c3

M3 - Article

C2 - 24022057

AN - SCOPUS:84894101219

VL - 18

SP - 57

EP - 60

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 1

ER -